Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | CSNK1G1 | Q9HCP0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5012592 | 0.76 | LMNA (0.52) | LMNAPIM1GSK3AGSK3BPIM3 | |
| SCHEMBL5009339 | 0.76 | LMNA (0.52) | LMNAPIM1GSK3AGSK3BPIM3 | |
| SCHEMBL11081587 | 0.72 | ALDH1A1 (0.35) | — | |
| SCHEMBL20468385 | 0.71 | KDM4E (0.52) | — | |
| Nadifloxacin SCHEMBL3818938 | 0.67 | LMNA (1.00) | LMNA | |
| Nadifloxacin SCHEMBL36593 | 0.67 | LMNA (1.00) | LMNA | |
| Levonadifloxacin SCHEMBL3972618 | 0.66 | LMNA (0.98) | LMNA | |
| SCHEMBL116307 | 0.65 | POLB (0.30) | — | |
| SCHEMBL12820265 | 0.65 | ALDH1A1 (0.52) | PIM1GSK3AGSK3BPIM3CSNK1G1 | |
| SCHEMBL4638291 | 0.65 | LMNA (0.78) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607084-A1 | A METHOD FOR TESTING ANTIMICROBIAL SUSCEPTIBILITY | The University Of Western Australia (AU) | 2020-02-12 | — | — | EP | disclosed |
| WO-2018184073-A1 | A METHOD FOR TESTING ANTIMICROBIAL SUSCEPTIBILITY | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2018-10-11 | — | — | WO | disclosed |